Biogen, Inc. (NQ: BIIB )

267.12 USD -1.65 (-0.61%)

Official Closing Price Updated: 7:59 PM EDT, Oct 20, 2020 Add to My Watchlist

Price and Volume

Volume	1,156,100
Open	270.45
Bid (Size)	270.00 (2)
Ask (Size)	272.00 (1)
Prev. Close	268.77
Today's Range	266.09 - 271.98
52wk Range	221.56 - 374.99
Shares Outstanding	211,007,945
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

Abarca Details First Value-Based Agreement For Medicaid Members Prescribed Biogen Products

October 20, 2020

Case Study highlights how a Medicaid Plan now receives rebates from Biogen for patients who discontinued their treatment with Avonex® (interferon beta-1a) and Tecfidera® (dimethyl fumarate)

Top Pharmaceutical Stocks To Capitalize On U.S. Vaccine Hopes

October 19, 2020

Performance

YTD	-9.22%	-9.22%
1 Month	-0.44%	-0.44%
3 Month	-4.66%	-4.66%
6 Month	-18.81%	-18.81%
1 Year	+19.51%	+19.51%

More News

Orphan Drugs Market 2020 | Global Industry Overview, Sales Revenue, Demand and Opportunity 2025

October 15, 2020

Samsung Bioepis and Biogen Announce EMA Filing Acceptance of SB11, a Proposed Biosimilar Referencing Lucentis® (ranibizumab)

October 06, 2020

Notable Tuesday Option Activity: BIIB, GM, LMT

October 20, 2020

Biogen Employee Catalyzes Economic Empowerment for Minority-Owned Business

September 29, 2020

Scribe Therapeutics to Collaborate With Biogen to Develop CRISPR-based Genetic Medicines for Neurological Diseases, Including Amyotrophic Lateral Sclerosis

October 06, 2020

Biogen's Earnings Outlook

October 20, 2020

Price Over Earnings Overview: Biogen

October 20, 2020

MGV's Underlying Holdings Could Mean 12% Gain Potential

October 20, 2020

Chipotle, Tesla Near Buy Points Ahead Of Earnings: Investing Action Plan

October 20, 2020

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.